EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The origin of patient-derived cancer organoids from pathologically undiagnosed specimen in patients with pancreatobiliary cancers

Bomi Kim, Jiho Park, Hee Young Na, Sinwoo Park, Jeonghwa Jin, Kwangrok Jung, Jong-Chan Lee, Jin-Hyeok Hwang, Minseok Seo, Jaihwan Kim

Cellular Oncology · 2025

DOI: 10.1007/s13402-024-01026-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Bomi Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Organoids, Pancreatic Neoplasms, Gallbladder Neoplasms, Biliary Tract Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Tissue confirmation of pancreatobiliary cancer is often difficult because of the location of the tumor and structure of the surrounding blood vessels. Patient-derived cancer organoids (PDCOs) reflect the genomic characteristics of individual cancers. Although diverse attempts to construct PDCOs for various pancreatobiliary cancer models are ongoing, no research results have yet confirmed the possibility of performing a precise diagnosis on PDCOs derived from pathologically negative patient samples.

Methods

We obtained a total of nine samples, including pathologically negative samples, from four patients (three patients with pancreatic cancer and one patient with gallbladder cancer) using different tissue acquisition methods to establish PDCOs (success rate 75%).

Results

We successfully verified whether the constructed PDCOs could represent the tissues of patients with pancreatobiliary cancer at each multi-omics level using tumor panel sequencing, single-cell RNA sequencing, hematoxylin and eosin, and immunohistochemical staining. PDCOs from pathologically negative samples showed expression patterns of malignant ductal cell-related biomarkers similar to those of other pathologically positive samples. Furthermore, the expression patterns at the single-cell level in PDCO from patients ultimately diagnosed with gallbladder cancer after surgery were different from those in patients with pancreatic cancer.

Conclusion

Therefore, our study implicated the potential of PDCOs as diagnostic and research tools, including for case involving limited tissue samples. Based on these results, we anticipate that this could be extended to more advanced studies, such as drug sensitivity testing, through large-scale trials in the near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsPancreatic NeoplasmsGallbladder NeoplasmsBiliary Tract NeoplasmsHumansMaleFemaleMiddle AgedAgedBiomarkers, Tumor

Stichwörter der Autor:innen

Gallbladder cancerPancreatic cancerPatient derived cancer organoidPrecision therapySingle-cell RNA sequencing

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Next & Bio Inc., Seoul, Korea.
  • Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Department of Computer and Information Science, Korea University, Sejong, Korea.
  • Department of Computer and Information Science, Korea University, Sejong, Korea. mins@korea.ac.kr.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. drjaihwan@snu.ac.kr.

Förderung

  • Seoul National University

Zitieren

APA

Kim, B., Park, J., Na, H. Y., Park, S., Jin, J., Jung, K., Lee, J. C., Hwang, J. H., Seo, M., & Kim, J. (2025). The origin of patient-derived cancer organoids from pathologically undiagnosed specimen in patients with pancreatobiliary cancers. Cellular Oncology. https://doi.org/10.1007/s13402-024-01026-5

Vancouver

Kim B, Park J, Na HY, Park S, Jin J, Jung K, et al. The origin of patient-derived cancer organoids from pathologically undiagnosed specimen in patients with pancreatobiliary cancers. Cellular Oncology. 2025. doi:10.1007/s13402-024-01026-5

BibTeX
@article{Kim2025,
  author = {Kim, Bomi and Park, Jiho and Na, Hee Young and Park, Sinwoo and Jin, Jeonghwa and Jung, Kwangrok and Lee, Jong-Chan and Hwang, Jin-Hyeok and Seo, Minseok and Kim, Jaihwan},
  title = {The origin of patient-derived cancer organoids from pathologically undiagnosed specimen in patients with pancreatobiliary cancers},
  journal = {Cellular Oncology},
  year = {2025},
  doi = {10.1007/s13402-024-01026-5}
}
Kostenlos starten →